Alternative Investments: Direxion Launches Inverse ETFs To Bet Against Amazon, Google, And Microsoft

September 8, 2022 | Alternative Investments, News
https://dailyalts.com/wp-content/uploads/2022/09/child-g19b7bebd3_640.jpg

The Direxion ETFs allow active traders to obtain inverse exposure to the daily performance of the common stocks of Amazon, Google or Microsoft.

Direxion, provider of tradeable and thematic ETFs, announced the launch of an additional six single stock leveraged and inverse ETFs, listing on the NASDAQ. These new ETFs follow on the firm’s previously introduced four single stock leveraged and inverse ETFs, namely TSLL, TSLS, AAPU, and AAPD. (Yahoo Finance)

The new ETFs are as follows:

Direxion Daily AMZN Bull 1.5X Shares

AMZU

Direxion Daily AMZN Bear 1X Shares

AMZD

Direxion Daily GOOGL Bull 1.5X Shares

GGLL

Direxion Daily GOOGL Bear 1X Shares

GGLS

Direxion Daily MSFT Bull 1.5X Shares

MSFU

Direxion Daily MSFT Bear 1X Shares

MSFD

“Amazon, Google and Microsoft are three of the world’s largest stocks, are heavily traded, and are widely recognized,” said Managing Director and Head of Product, David Mazza. “The ability to express short-term views on single stocks using a Bull or Bear fund is an excellent way for traders to respond tactically to potential company events and market moves.”

The features of these single stock ETFS are:

· Built for active traders

· Meant to be used for short-term trading purposes

· Should not be viewed as buy and hold investments

· Rather they are trading tools for traders with a high risk tolerance

· Unlike traditional ETFs, or even other levered and/or inverse ETFs, these ETFs track the price of a single stock rather than an index

· They therefore eliminate the benefits of diversification

· The ETFs do not invest directly in Amazon (NASDAQ: AMZN), Google (NASDAQ: GOOGL) or Microsoft (NASDAQ: MSFT)

· Intended only for investors with an in-depth understanding of the risks associated with seeking leveraged or inverse investment results

· Meant for traders who plan to actively monitor and manage their positions

· There is no guarantee these ETFs will meet their objective

Related Story: Direxion Launches Four Single Stock Leveraged ETFs Including Inverse 1X Apple And Tesla

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Shape

Latest Alternative Investment News

https://dailyalts.com/wp-content/uploads/2023/09/0deafbe2-9873-4d57-aaaf-ecb37a567e1a__IC21947.jpg
Digital Assets: 1% Of Chileans Sign Up For Worldcoin; Rush Seen In Argentina, Too
September 28, 2023     Digital Assets, News

Worldcoin, the innovative biometric wallet and ID project, is making significant waves in Chile as it surpasses a remarkable milestone. The organization has reported that over 200,000 Chileans have embraced…

https://dailyalts.com/wp-content/uploads/2023/09/1695822001308.jpg
FinTech: Atom Bank And Kamma To Partner For Greening UK Mortgage Assets
September 28, 2023     ESG and Sustainability, FinTech, News, Real Estate

Atom bank and Kamma have formed a significant partnership aimed at addressing the pressing concerns of climate change. This collaboration brings together Atom bank’s cutting-edge banking technology with Kamma’s climate…

https://dailyalts.com/wp-content/uploads/2023/09/0_onaeojfgCZeyNabT.jpg
Venture Capital: Slope, A B2B Solutions Provider Backed By Sam Altman, Scores $30M Funding

Slope, a two-year-old AI startup based in San Francisco, has secured a substantial $30 million equity round led by Union Square Ventures and featuring participation from OpenAI’s CEO, Sam Altman….

https://dailyalts.com/wp-content/uploads/2023/09/32215763362_b62ef08e5f_c.jpg
Artificial Intelligence: Palantir Awarded $250M Contract By US Department Of Defense For AI R&D
September 28, 2023     Artificial Intelligence, Latest News, News

Palantir Technologies Inc. (NYSE: PLTR) has secured a significant contract worth $250 million with the US Defense Department. The primary focus of this contract is the research and development of…